🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The company stated it was dedicated to keeping the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, positive testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of joining one group, a vendor shared contact information, where most purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, messages show black plastic packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to possibly serious health risks”.